Company intelligence / Profile preview

SweetSpot

Portland, Oregon, United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

SweetSpot's platform, used in clinical settings, reports increased Time in Range (TIR) by >10% and HbA1c reduction of >1% for diabetes patients leveraging frequent data reviews; results from a clinical study will be published in 2025[9].

Therapeutic areas: Endocrinology
Modalities: DeviceData management platformNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Endocrinology practices partnering for remote CGM data management

Beyond the preview

Go deeper on SweetSpot.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SweetSpot.

Explore the full profile